Debu Tripathy

The University of Texas MD Anderson Cancer Center

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Data from Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6532592

Top 100%

0DataRank

Top 100%0 citations

Nour Abuhadra, Ryan Sun, Beatriz E. Adrada, Qingqing Ding, Jason B. White +22 more

Papers

Driven by 56 papers — median percentile 0. Top paper: “Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial”.

Improved tolerability of neratinib in patients with HER2-positive early-stage breast cancer: the CONTROL trial

Annals of Oncology(2020)10.1016/j.annonc.2020.05.012

N/A

3.1DataRank · unranked

106 citations

Sara A. Hurvitz, Jack A. Di Palma, Ron Bose, A. Jo Chien, Nicholas Iannotti +48 more

Cisplatin with veliparib or placebo in metastatic triple-negative breast cancer and BRCA mutation-associated breast cancer (S1416): a randomised, double-blind, placebo-controlled, phase 2 trial

The Lancet Oncology(2023)10.1016/s1470-2045(22)00739-2

N/A

2.0DataRank · unranked

102 citations

Priyanka Sharma, William E. Barlow, Julie R. Gralow, Shannon L. Puhalla, Carey K. Anders +16 more

MRI-Based Digital Models Forecast Patient-Specific Treatment Responses to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Cancer Research(2022)10.1158/0008-5472.can-22-1329

N/A

1.6DataRank · unranked

75 citations

Angela M. Jarrett, Zijian Zhou, Nabil Elshafeey, Beatriz E. Adrada, Rosalind P. Candelaria +13 more

Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-21-3100

N/A

1.3DataRank · unranked

42 citations

Nour Abuhadra, Ryan Sun, Beatriz E. Adrada, Qingqing Ding, Jason B. White +22 more

A Radiomics Model Based on Synthetic MRI Acquisition for Predicting Neoadjuvant Systemic Treatment Response in Triple-Negative Breast Cancer

Radiology Imaging Cancer(2023)10.1148/rycan.230009

N/A

1.0DataRank · unranked

31 citations

Nabil Elshafeey, Aikaterini Kotrotsou, Huiqin Chen, Jong Bum Son, Medine Böge +21 more

Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy

Cancer Cell(2023)10.1016/j.ccell.2023.04.008

N/A

0.777DataRank · unranked

177 citations

Lamorna Brown Swigart, Ziad Ahmed, Rosalyn W. Sayaman, Derrick Renner, Ekaterina Kalashnikova +26 more

Circulating tumor DNA and magnetic resonance imaging to predict neoadjuvant chemotherapy response and recurrence risk

npj Breast Cancer(2021)10.1038/s41523-021-00239-3

N/A

0.598DataRank · unranked

53 citations

Wen Li, Denise M. Wolf, Christina Yau, Gillian L. Hirst, Lamorna Brown Swigart +12 more

Phase I trial of hydroxychloroquine to enhance palbociclib and letrozole efficacy in ER+/HER2− breast cancer

npj Breast Cancer(2025)10.1038/s41523-025-00722-1

N/A

0.550DataRank · unranked

18 citations

Nicole M. Kettner, Danielle Kwiatkowski, Senthil Damodaran, Yan Wang, David L. Ramírez +6 more

Aerobic and resistance exercise improves Reynolds risk score in overweight or obese breast cancer survivors

Cardio-Oncology(2020)10.1186/s40959-020-00084-6

N/A

0.518DataRank · unranked

8 citations

Nathalie Sami, Debu Tripathy, Wendy Demark‐Wahnefried, Mary K. Norris, Kerry S. Courneya +2 more

Maternal Embryonic Leucine Zipper Kinase is Associated with Metastasis in Triple-negative Breast Cancer

Cancer Research Communications(2023)10.1158/2767-9764.crc-22-0330

N/A

0.373DataRank · unranked

11 citations

Gaurav B. Chauhan, Ramakrishna Edupuganti, Takahiro Kogawa, Jihyun Park, Moises Tacam +20 more

Identification of Kinase Targets for Enhancing the Antitumor Activity of Eribulin in Triple-Negative Breast Cell Lines

Biomedicines(2023)10.3390/biomedicines11030735

N/A

0.345DataRank · unranked

9 citations

Jangsoon Lee, Jon A. Fuson, Huey Liu, Toshiaki Iwase, Kyuson Yun +4 more

Genomic and transcriptomic analyses identify distinctive features of triple-negative inflammatory breast cancer

npj Precision Oncology(2024)10.1038/s41698-024-00729-0

N/A

0.298DataRank · unranked

5 citations

Li Zhao, Xingzhi Song, Xiaogang Wu, Savitri Krishnamurthy, Takashi Semba +63 more

Targeting chemotherapy resistance in mesenchymal triple-negative breast cancer: a phase II trial of neoadjuvant angiogenic and mTOR inhibition with chemotherapy

Investigational New Drugs(2023)10.1007/s10637-023-01357-4

N/A

0.285DataRank · unranked

5 citations

Ryan Sun, Roland L. Bassett, Lei Huo, Jeffrey T. Chang, Mediget Teshome +24 more

Abemaciclib Is Effective in Palbociclib-Resistant Hormone Receptor–Positive Metastatic Breast Cancers

Cancer Research(2023)10.1158/0008-5472.can-23-0705

N/A

0DataRank · unranked

53 citations

Nicole M. Kettner, Xiayu Rao, Cassandra Santaella Bishop, Tuyen Bui, Hannah F. Wingate +10 more

Prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer using deep learning on multiparametric MRI

Scientific Reports(2023)10.1038/s41598-023-27518-2

N/A

0DataRank · unranked

44 citations

Beatriz E. Adrada, Rosalind P. Candelaria, Nabil Elshafeey, Medine Böge, Rania M. Mohamed +22 more

Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan

npj Breast Cancer(2023)10.1038/s41523-023-00573-8

N/A

0DataRank · unranked

29 citations

Timothy P. DiPeri, Maria Gabriela Raso, Xiaofeng Zheng, Yasmeen Qamar Rizvi, Kurt W. Evans +8 more

Assessment of Response to Neoadjuvant Systemic Treatment in Triple-Negative Breast Cancer Using Functional Tumor Volumes from Longitudinal Dynamic Contrast-Enhanced MRI

Cancers(2023)10.3390/cancers15041025

N/A

0DataRank · unranked

25 citations

Beatriz E. Adrada, Rosalind P. Candelaria, Mary S. Guirguis, Clinton Yam, Medine Böge +26 more

Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial—Efficacy and Biomarker Discovery

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-22-2256

N/A

0DataRank · unranked

20 citations

Christina Yau, Emanuel F. Petricoin, Denise M. Wolf, Julie E. Lang, A. Jo Chien +44 more

Deep Learning for Fully Automatic Tumor Segmentation on Serially Acquired Dynamic Contrast-Enhanced MRI Images of Triple-Negative Breast Cancer

Cancers(2023)10.3390/cancers15194829

N/A

0DataRank · unranked

9 citations

David E Rauch, Rania M. Mohamed, Sanaz Pashapoor, Zijian Zhou, Bikash Panthi +26 more

Longitudinal dynamic contrast-enhanced MRI radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer

Frontiers in Oncology(2023)10.3389/fonc.2023.1264259

N/A

0DataRank · unranked

10 citations

Rania M. Mohamed, Beatriz E. Adrada, Medine Böge, Rosalind P. Candelaria, Huiqin Chen +24 more

The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody-drug conjugate–resistant HER2-overexpressing breast cancer

Research Square(2023)10.21203/rs.3.rs-2918702/v1

N/A

0DataRank · unranked

2 citations

Kumiko Kida, Huey Liu, Ganiraju C. Manyam, Young Jin Gi, Asha S. Multani +7 more

Predicting pathological complete response to neoadjuvant systemic therapy for triple-negative breast cancers using deep learning on multiparametric MRIs

PubMed(2023)10.1109/embc40787.2023.10340987

N/A

0DataRank · unranked

2 citations

Beatriz E. Adrada, Rosalind P. Candelaria, Nabil Elshafeey, Medine Böge, Rania M. Mohamed +22 more

Data from MRI-Based Digital Models Forecast Patient-Specific Treatment Responses to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

(2023)10.1158/0008-5472.c.6514223.v1

N/A

0DataRank · unranked

0 citations

Angela M. Jarrett, Zijian Zhou, Nabil Elshafeey, Beatriz E. Adrada, Rosalind P. Candelaria +13 more

Data from MRI-Based Digital Models Forecast Patient-Specific Treatment Responses to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

(2023)10.1158/0008-5472.c.6514223

N/A

0DataRank · unranked

0 citations

Angela M. Jarrett, Zijian Zhou, Nabil Elshafeey, Beatriz E. Adrada, Rosalind P. Candelaria +13 more

Data from Combined Inhibition of STAT3 and DNA Repair in Palbociclib-Resistant ER-Positive Breast Cancer

(2023)10.1158/1078-0432.c.6529199

N/A

0DataRank · unranked

0 citations

Smruthi Vijayaraghavan, Merih Güray Durak, Tuyen Bui, Mehrnoosh Kohansal, Min Jin Ha +17 more

Data from Molecular Characterization and Prospective Evaluation of Pathologic Response and Outcomes with Neoadjuvant Therapy in Metaplastic Triple-Negative Breast Cancer

(2023)10.1158/1078-0432.c.6532592

Top 100%

0DataRank

Top 100%0 citations

Nour Abuhadra, Ryan Sun, Beatriz E. Adrada, Qingqing Ding, Jason B. White +22 more

Data from Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy

(2023)10.1158/1541-7786.c.6545651

N/A

0DataRank · unranked

0 citations

Ayca Nazli Mogol, Yu-Jeh Liu, Ashlie Santaliz Casiano, Christine Chien, Jenny Drnevich +13 more

Supplementary Table from Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy

(2023)10.1158/1541-7786.22528217

Top 100%

0DataRank

Top 100%0 citations

Ayca Nazli Mogol, Yu-Jeh Liu, Ashlie Santaliz Casiano, Christine Chien, Jenny Drnevich +13 more

Cyclic fasting-mimicking diet in cancer treatment: Preclinical and clinical evidence

Cell Metabolism(2024)10.1016/j.cmet.2024.06.014

N/A

0DataRank · unranked

37 citations

Francesca Ligorio, Debu Tripathy, Valter D. Longo, Claudio Vernieri

The DNA repair pathway as a therapeutic target to synergize with trastuzumab deruxtecan in HER2-targeted antibody–drug conjugate–resistant HER2-overexpressing breast cancer

Journal of Experimental & Clinical Cancer Research(2024)10.1186/s13046-024-03143-3

N/A

0DataRank · unranked

27 citations

Kumiko Kida, Jiwon Koh, Huey Liu, Ganiraju C. Manyam, Young Jin Gi +12 more

Monitoring response to neoadjuvant chemotherapy in triple negative breast cancer using circulating tumor DNA

BMC Cancer(2024)10.1186/s12885-024-12689-6

N/A

0DataRank · unranked

26 citations

Sridevi Addanki, Dhruvajyoti Roy, Roland L. Bassett, Ekaterina Kalashnikova, Erik Spickard +16 more

Antitumor Activity and Biomarker Analysis for TROP2 Antibody–Drug Conjugate Datopotamab Deruxtecan in Patient-Derived Breast Cancer Xenograft Models

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1948

N/A

0DataRank · unranked

22 citations

Erkan Yuca, Kurt W. Evans, Ming Zhao, Takanori Maejima, Tsuyoshi Karibe +12 more

Clinical outcomes of early-stage triple-negative breast cancer after neoadjuvant chemotherapy according to HER2-low status☆

ESMO Open(2024)10.1016/j.esmoop.2024.103973

N/A

0DataRank · unranked

12 citations

Danielle Brandes Zakon, Qingchun Jin, Ava Strahan, Melissa Grimm, Melissa E. Hughes +15 more

Patient-reported convenience and effectiveness of telehealth for breast cancer management

The Oncologist(2024)10.1093/oncolo/oyae165

N/A

0DataRank · unranked

7 citations

Kristofer Jennings, Gil Guerra‐Júnior, Debu Tripathy, Meghan Karuturi, Akshara Singareeka Raghavendra

Diffusion Tensor Imaging for Characterizing Changes in Triple‐Negative Breast Cancer During Neoadjuvant Systemic Therapy

Journal of Magnetic Resonance Imaging(2024)10.1002/jmri.29267

N/A

0DataRank · unranked

5 citations

David E Rauch, Rania M. Mohamed, Bikash Panthi, Medine Böge, Rosalind P. Candelaria +24 more

Distress and inflammation are independently associated with cancer-related symptom severity

Comprehensive Psychoneuroendocrinology(2024)10.1016/j.cpnec.2024.100269

N/A

0DataRank · unranked

1 citations

Debu Tripathy, Maria C. Swartz, Emily C. LaVoy, Cobi J. Heijnen, Tamara E. Lacourt

Reshaping the Landscape of Locoregional Treatments for Breast Cancer Liver Metastases: A novel, intratumoral, p21-targeted percutaneous therapy increases survival in BALB/c mice inoculated with 4T1 triple negative breast cancer cells in the liver

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.11.27.625706

N/A

0DataRank · unranked

1 citations

Morakot Likhitpanichkul, Debu Tripathy, Bryan S. Margulies

Monitoring Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer Using Circulating Tumor DNA

Research Square(2024)10.21203/rs.3.rs-4104393/v1

N/A

0DataRank · unranked

0 citations

Sridevi Addanki, Dhruvajyoti Roy, Roland L. Bassett, Ekaterina Kalashnikova, Erik Spickard +16 more

IL-6 predicts CDK4/6 inhibitor resistance, identifying STAT3 as a target in HR + /HER2-negative metastatic breast cancer

npj Precision Oncology(2025)10.1038/s41698-025-01041-1

N/A

0DataRank · unranked

14 citations

Tuyen Bui, Juliana Navarro-Yepes, Sanaz Ghotbaldini, Bethanie Quintela, Catherine K. Luo +19 more

AXL promotes inflammatory breast cancer progression by regulating immunosuppressive macrophage polarization

Breast Cancer Research(2025)10.1186/s13058-025-02015-8

N/A

0DataRank · unranked

7 citations

Yating Cheng, Yohei Funakoshi, François Bertucci, Pascal Finetti, Steven Van Laere +13 more

Early tumor volume reduction by breast DCE MRI predicts pathologic complete response to neoadjuvant therapy in triple negative breast cancer

npj Breast Cancer(2025)10.1038/s41523-025-00839-3

N/A

0DataRank · unranked

3 citations

Beatriz E. Adrada, Clinton Yam, Debu Tripathy, Rosalind P. Candelaria, Wei Yang +25 more

Inhibition of MCL-1 and MEK Overcomes MEK Inhibitor Resistance in Triple-Negative and Inflammatory Breast Cancers

Molecular Cancer Therapeutics(2025)10.1158/1535-7163.mct-24-0593

N/A

0DataRank · unranked

2 citations

Moises Tacam, Alex W. Tan, Mary Kathryn Pitner, LaKesla R. Iles, Xiaoding Hu +16 more

Circulating tumor DNA in neoadjuvant-treated breast cancer reflects response and survival

Annals of Oncology(2020)10.1016/j.annonc.2020.11.007

N/A

0DataRank · unranked

445 citations

Lamorna Brown Swigart, H.-T. Wu, Gillian L. Hirst, Christina Yau, Denise M. Wolf +19 more

Adjuvant capecitabine in patients with triple-negative breast cancer after neoadjuvant chemotherapy

ESMO Open(2025)10.1016/j.esmoop.2025.105568

N/A

0DataRank · unranked

1 citations

Qi Jin, Agepati S. Raghavendra, Danielle Brandes Zakon, Melissa Grimm, Melissa E. Hughes +16 more

Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer

Scientific Reports(2020)10.1038/s41598-020-65250-3

N/A

0DataRank · unranked

50 citations

Mary Kathryn Pitner, Jihyun Park, Xuemei Xie, Hitomi Saso, Richard Larson +12 more

Aerobic and Resistance Exercise Improves Reynolds Risk Score in Overweight or Obese Breast Cancer Survivors

Research Square(2020)10.21203/rs.3.rs-59386/v2

N/A

0DataRank · unranked

2 citations

Nathalie Sami, Debu Tripathy, Wendy Demark‐Wahnefried, Mary K. Norris, Kerry S. Courneya +2 more

Aerobic and Resistance Exercise Improves Reynolds Risk Score in Overweight or Obese Breast Cancer Survivors

Research Square(2020)10.21203/rs.3.rs-59386/v1

N/A

0DataRank · unranked

1 citations

Kyuwan Lee, Nathalie Sami, Debu Tripathy, Wendy Demark‐Wahnefried, Mary K. Norris +2 more

Neoadjuvant T-DM1/pertuzumab and paclitaxel/trastuzumab/pertuzumab for HER2+ breast cancer in the adaptively randomized I-SPY2 trial

Nature Communications(2021)10.1038/s41467-021-26019-y

N/A

0DataRank · unranked

73 citations

Christina Yau, Denise M. Wolf, Emanuel F. Petricoin, L. J. van ‘t Veer, Douglas Yee +46 more

Predicted sensitivity to endocrine therapy for stage II-III hormone receptor-positive and HER2-negative (HR+/HER2−) breast cancer before chemo-endocrine therapy

Annals of Oncology(2021)10.1016/j.annonc.2021.02.011

N/A

0DataRank · unranked

45 citations

Christina Yau, Lamorna Brown Swigart, Rebekah Gould, Gregor Krings, Gillian L. Hirst +27 more

Ganitumab and metformin plus standard neoadjuvant therapy in stage 2/3 breast cancer

npj Breast Cancer(2021)10.1038/s41523-021-00337-2

N/A

0DataRank · unranked

29 citations

Claudine Isaacs, Denise M. Wolf, Christina Yau, Paul Haluska, Karthik V. Giridhar +50 more

PI3K and MAPK Pathways as Targets for Combination with the Pan-HER Irreversible Inhibitor Neratinib in HER2-Positive Breast Cancer and TNBC by Kinome RNAi Screening

Biomedicines(2021)10.3390/biomedicines9070740

N/A

0DataRank · unranked

19 citations

Huey Liu, Troy Pearson, Toshiaki Iwase, Jon A. Fuson, Alshad S. Lalani +6 more

Nonphosphorylatable PEA15 mutant inhibits epithelial-mesenchymal transition in triple-negative breast cancer partly through the regulation of IL-8 expression

Breast Cancer Research and Treatment(2021)10.1007/s10549-021-06316-2

N/A

0DataRank · unranked

4 citations

Moises Tacam, Gaurav B. Chauhan, Evan N. Cohen, Maria Gagliardi, LaKesla R. Iles +13 more

Phase I safety and efficacy study of autophagy inhibition with hydroxychloroquine to augment the antiproliferative and biological effects of preoperative palbociclib plus letrozole for estrogen receptor-positive, HER2-negative metastatic breast cancer (MBC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.1067

N/A

0DataRank · unranked

3 citations

Danielle Kwiatkowski, Senthil Damodaran, Nicole M. Kettner, David L. Ramírez, Dan S. Gombos +5 more

Targeting Metabolic Adaptations in the Breast Cancer–Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy

Molecular Cancer Research(2022)10.1158/1541-7786.mcr-21-0781

N/A

0DataRank · unranked

24 citations

Ayca Nazli Mogol, Yu-Jeh Liu, Ashlie Santaliz Casiano, Christine Chien, Jenny Drnevich +13 more

Histology-based survival outcomes in hormone receptor-positive metastatic breast cancer treated with targeted therapies

npj Breast Cancer(2022)10.1038/s41523-022-00499-7

N/A

0DataRank · unranked

19 citations

Akshara Singareeka Raghavendra, Roland L. Bassett, Amy Hassan, Debu Tripathy, Rachel M. Layman +1 more

Quantitative Apparent Diffusion Coefficients From Peritumoral Regions as Early Predictors of Response to Neoadjuvant Systemic Therapy in Triple‐Negative Breast Cancer

Journal of Magnetic Resonance Imaging(2022)10.1002/jmri.28219

N/A

0DataRank · unranked

13 citations

Beatriz E. Adrada, Rosalind P. Candelaria, Rania M. Mohamed, Abeer H. Abdelhafez, Jong Bum Son +23 more

Debu Tripathy

Indexed papers

Top data-sharing exemplar

Papers